Augmedix (OTCMKTS:AUGX – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, Zacks.com reports. The brokerage currently has a $2.50 target price on the stock. Zacks Investment Research‘s target price points to a potential upside of 23.76% from the […]
Augmedix (OTCMKTS:AUGX – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, Zacks.com reports. According to Zacks, “Augmedix Inc. is a provider of remote medical documentation and live clinical support. Augmedix Inc. is based in SAN FRANCISCO, Calif. “ […]
Shares of Augmedix, Inc. (OTCMKTS:AUGX – Get Rating) have received an average rating of “Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have issued ratings on the stock in […]
Augmedix (OTCMKTS:AUGX – Get Rating) is one of 226 public companies in the “Business services, not elsewhere classified” industry, but how does it contrast to its competitors? We will compare Augmedix to related companies based on the strength of its risk, valuation, analyst recommendations, profitability, dividends, institutional ownership and earnings. Valuation and Earnings This table […]
Zacks Investment Research cut shares of Augmedix (OTCMKTS:AUGX – Get Rating) from a hold rating to a sell rating in a report published on Wednesday, Zacks.com reports. According to Zacks, “Augmedix Inc. is a provider of remote medical documentation and live clinical support. Augmedix Inc. is based in SAN FRANCISCO, Calif. “ A number of […]